Cargando…

Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing

The t(11;14) (q13;q32) translocation resulting in overexpression of cyclin D1 is the major oncogenic mechanism in mantle cell lymphoma (MCL). Most MCLs can be diagnosed based on morphological features, cyclin D1 expression, and IGH/CCND1 rearrangement. However, in some atypical cases where conventio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Luomengjia, Zhang, Han, Chen, Wen, Xia, Yi, Qin, Shuchao, Shao, Yang, Li, Jianyong, Miao, Yi, Li, Bingzong, Zhu, Huayuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090691/ https://www.ncbi.nlm.nih.gov/pubmed/37064110 http://dx.doi.org/10.3389/fonc.2023.1145376

Ejemplares similares

P607: INTEGRATING MULTI-OMICS TO REVEAL THE CLONAL EVOLUTIONARY CHARACTERISTICS IN CLL PATIENTS WITH ZANUBRUTINIB RESISTANCE
por: Zhu, Huayuan, et al.
Publicado: (2023)

P592: SINGLE-CELL RNA SEQUENCING REVEALS THE SPATIAL HETEROGENEITY OF EXHAUSTED T CELLS IN BTKI-RESISTANT RICHTER TRANSFORMATION PATIENTS
por: Sha, Yeqin, et al.
Publicado: (2023)

First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation
por: Liu, Hailing, et al.
Publicado: (2022)

Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma
por: Masamha, Chioniso Patience, et al.
Publicado: (2016)

CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma
por: Mohanty, Atish, et al.
Publicado: (2016)

Aberrant somatic hypermutation of CCND1 generates non-coding drivers of mantle cell lymphomagenesis
por: Müller, Heiko, et al.
Publicado: (2022)

Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort
por: Miao, Yi, et al.
Publicado: (2023)

Atypical cytologic mantle cell lymphoma presentation
por: Chea, Mathias, et al.
Publicado: (2022)

CD5-negative Blastoid Variant Mantle Cell Lymphoma with Complex CCND1/IGH and MYC Aberrations
por: Seok, Yoonmi, et al.
Publicado: (2012)

Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma
por: Zhang, Jing, et al.
Publicado: (2022)

CCND1 Genomic Rearrangement as a Secondary Event in High Grade B-Cell Lymphoma
por: Cheng, Jinjun, et al.
Publicado: (2020)

Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma
por: Krieger, Sophie, et al.
Publicado: (2006)

P1250: EU-SOX11CCND1: A NOVEL IMMUNOCOMPETENT MURINE MODEL OF MANTLE CELL LYMPHOMA
por: Brown, F., et al.
Publicado: (2022)

USP9X Increased Tumor Angiogenesis in Mantle Cell Lymphoma by Upregulation of CCND1-Mediated SOX11
por: Huang, Gang, et al.
Publicado: (2022)

SAMHD1 Mutations and Expression in Mantle Cell Lymphoma Patients
por: Wang, Tao, et al.
Publicado: (2021)

Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma
por: Wang, Hongyu, et al.
Publicado: (2023)

A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma
por: Rather, Gulam M., et al.
Publicado: (2019)

Clinicopathologic study of mantle cell lymphoma with epstein-barr virus infection: A case series and literature review
por: Li, Xiaoju, et al.
Publicado: (2022)

Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas
por: Sethi, Shenon, et al.
Publicado: (2021)

CCND2 mRNA Expression Is Correlated With R-CHOP Treatment Efficacy and Prognosis in Patients With ABC-DLBCL
por: Wang, Di, et al.
Publicado: (2020)

Next-generation sequencing based detection of BRCA1 and BRCA2 large genomic rearrangements in Chinese cancer patients
por: Hua, Dingchao, et al.
Publicado: (2022)

Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets
por: Miao, Yi, et al.
Publicado: (2019)

The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas
por: Tomacinschii, Victor, et al.
Publicado: (2023)

Composite Diffuse Large B-cell and Mantle Cell Lymphoma: A Case Report
por: Mohammad, Farhan, et al.
Publicado: (2017)

Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis
por: Guarnera, Luca, et al.
Publicado: (2022)

High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis
por: Li, Philippa, et al.
Publicado: (2021)

FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration
por: Li, Chun-Ming, et al.
Publicado: (2023)

G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Mantle Cell Lymphoma Growth in Preclinical Models
por: Zhou, Lixia, et al.
Publicado: (2021)

Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis
por: Wu, Hongyu, et al.
Publicado: (2020)

MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma
por: Wang, Lifu, et al.
Publicado: (2020)

Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma Cells
por: Zhang, Qian, et al.
Publicado: (2019)

Diffuse Alveolar Hemorrhage Secondary to Ibrutinib Therapy in a Patient With Refractory Mantle Cell Lymphoma
por: Locke, Clifford B, et al.
Publicado: (2020)

Cyclin D1 + large B-cell lymphoma with altered CCND1 and BCL-6 rearrangements: a diagnostic challenge
por: Gao, Da, et al.
Publicado: (2019)

Prognostic Value of Heterogeneity Index Derived from Baseline (18)F-FDG PET/CT in Mantle Cell Lymphoma
por: Liu, Fei, et al.
Publicado: (2022)

Multiple primary malignancies in 788 Chinese patients with diffuse large B‐cell lymphoma
por: Zhang, Xuchang, et al.
Publicado: (2023)

Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma
por: Manni, Sabrina, et al.
Publicado: (2021)

Exploration of residual disease in stem cell products from mantle cell lymphoma using next-generation sequencing
por: Elkjær, Lea Amalia Lind, et al.
Publicado: (2022)

Conventional Treatments Cannot Improve Outcomes of Early-Stage Primary Breast Marginal Zone Lymphoma
por: Liu, Hailing, et al.
Publicado: (2021)

Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma
por: Dalland, Joanna C., et al.
Publicado: (2021)

P1214: CTPS1 ACTS AS A PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET IN MANTLE CELL LYMPHOMA
por: Ren, Yi-Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gv6aaaa8l57quvvjrmnhrelbls